The Current State of The Psychedelics Industry in 2024
Many individuals have discovered the benefits of psychedelics, from curious practitioners to open-minded entrepreneurs, from relieved consumers to supportive investors. Although psychedelics have long been misunderstood, the stigma of the “party drug” is dissipating rapidly.
This paper explores three research-backed psychedelic therapies: psilocybin, DMT, and ketamine. Let’s review these treatment methods and what this emerging industry must navigate to break into the mainstream.
Cannabis Whitepaper
What’s Covered
What Are Psychedelics?
Understanding what psychedelics are and what they are used to treat.
Relevant Research Reports
We examine research reports and help break them down to digestible pieces on information.
Insurance Landscape
What insurance policies psychedelics companies need.
